SCHEMBL7368779

SCHEMBL7368779

CC(=O)CC(c1ccccc1)N(C)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
OPRK1 P41145 2/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2A P28223 1/20 0.45
SLC6A4 P31645 1/20 0.45
ADRA1A P35348 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KCNH2 Q12809 1/20 0.45
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
HPGD P15428 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5321171 0.90 HTT (0.44) RAB9AALDH1A1KDM4EATMTACR1
SCHEMBL5322144 0.86 LMNA (0.47) HPGDALDH1A1KMT2AMEN1TACR1
SCHEMBL8605476 0.81 CHRNB2 (0.53) TDP1NPC1HTR2AALDH1A1KDM4E
SCHEMBL14017766 0.80 ADRA2B (0.50) TDP1NPC1RAB9AOPRK1ADRA2B
SCHEMBL13452589 0.80 ADRA2B (0.50) TDP1NPC1RAB9AOPRK1ADRA2B
SCHEMBL5164752 0.77 HTR2A (0.47) NPC1RAB9AOPRK1ADRA2BADRA2C
SCHEMBL19729281 0.75 ALDH1A1 (0.42) HTR2AALDH1A1KDM4EKMT2AMEN1
SCHEMBL27601264 0.75 NR4A2 (0.53) TDP1NPC1RAB9AOPRK1ADRA2B
SCHEMBL890170 0.73 KMT2A (0.56) NPC1RAB9AOPRK1ADRA2BADRA2C
SCHEMBL9267301 0.73 KMT2A (0.56) NPC1RAB9AOPRK1ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1204652-A1 NOVEL SUCCINATE DERIVATIVE COMPOUNDS USEFUL AS CYSTEINE PROTEASE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2002-05-15 EP disclosed
WO-2001009110-A1 NOVEL SUCCINATE DERIVATIVE COMPOUNDS USEFUL AS CYSTEINE PROTEASE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-02-08 WO disclosed